Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The UK Myeloma Forum (UKMF) is a professional organization and registered charity dedicated to improving the care and management of patients with myeloma and related plasma cell disorders in the United Kingdom. Comprising hematologists, scientists, and healthcare professionals, the Forum develops national evidence-based guidelines, promotes clinical research, and provides educational resources to the medical community. It plays a pivotal role in coordinating clinical trials and collaborating with organizations like Myeloma UK and the British Society for Haematology. The UKMF serves as a central hub for advancing clinical excellence and fostering innovation in the treatment of plasma cell dyscrasias.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UK Myeloma Forum.